Improving quality of life and outcomes for cancer patients, through the first noninvasive white blood cell monitoring device. Spun out from
@MIT
@La_UPM
Location: United States, Massachusetts, Boston
Employees: 1-10
Total raised: $11.8M
Investors 5
| Date | Name | Website |
| - | Health Tec... | hthvc.com |
| 27.07.2022 | MassVentur... | mass-ventu... |
| - | Blue Goose... | bluegoosec... |
| 08.03.2022 | Dorm Room ... | dormroomfu... |
| 10.03.2022 | Good Growt... | goodgrowth... |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 23.09.2022 | Series A | $5M | - | - |
| 23.09.2022 | Series A | $5M | IAG Capita... | - |
| 23.07.2019 | Seed | $1.8M | - | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 11.10.2022 | Leuko closes €5M Series A round | EIT Health-supported start-up Leuko has closed a Series A funding of €5 million. The new funding wil... | eithealth.... |
| 23.09.2022 | Leuko Raises $5M in Series A Funding | Leuko, an MIT startup developing a solution that enables at-home noninvasive white blood cell (WBC) ... | finsmes.co... |
| 27.05.2022 | EIT Health Catapult 2021-22 names winners | This year’s EIT Health Catapult competition crowned Ebenbuild, Leuko and SolasCure as champions at t... | eithealth.... |
| 06.12.2021 | 21 start-ups reach EIT Health Catapult Final | Twenty-one start-ups from across Europe have secured their places at the EIT Health Catapult Final. ... | eithealth.... |